And what all this means is that paradigms take far too long to shift, that complexity and nuance are ignored and also that money talks -- because we've all seen the evidence of pharmaceutical companies funding studies of drugs that conveniently leave out their worst side effects, or studies funded by food companies of their new products, massively exaggerating the health benefits of the products they're about to bring by market.
I što sve to znači jest da paradigmama treba previše da se promjene, kako se složenost i nijanse ignoriraju, i da novac govori -- jer smo svi vidjeli dokaz kako farmaceutske kompanije financiraju istraživanja o lijekovima koja konvencionalno izostavljaju njihove najgore efekte, ili studije koje financiraju prehrambene kompanije o njihovim novim proizvodima, koje masovno pretjeruju o zdravstvenim koristima proizvoda koje će plasirati na tržište.